• Mon news: Autolus enters CAR-T race with FDA approval. FDA clears clinical hold on Novavax. AbbVie schizophrenia trial failure. Cigna not pursuing Humana. GSK leaving BIO. See more on our front page

Biotech Protalix, Chiesi edge close to potential Fabry disease approval

cafead

Administrator
Staff member
  • cafead   May 28, 2020 at 11:22: AM
via Israeli biotech Protalix BioTherapeutics and partner Chiesi have sent off their Biologics License Application for rare disease hopeful pegunigalsidase alfa to the FDA.

article source